Company Filing History:
Years Active: 1992-1994
Title: Shigeyoshi Yasumura: Innovator in Biopharmaceuticals
Introduction
Shigeyoshi Yasumura is a notable inventor based in Tokyo, Japan, recognized for his contributions to the field of biopharmaceuticals. With a total of three patents, Yasumura has made significant advancements in the development of novel therapeutic agents that have the potential to enhance human health.
Latest Patents
Yasumura's latest patents focus on groundbreaking innovations in biochemistry. One of his prominent inventions is a plasminogen activator that closely resembles naturally occurring human prourokinase. This novel activator features a unique modification at the 155th amino acid position, substituting proline with an alternative amino acid, thereby expanding its potential therapeutic applications. Another significant patent involves a modified granulocyte-colony stimulating factor polypeptide, which utilizes recombinant DNA techniques to create a polypeptide or glycosylated polypeptide with enhanced protease resistance and thermal stability. This innovation is designed to prolong the polypeptide's lifetime in the bloodstream compared to its naturally occurring counterpart.
Career Highlights
Shigeyoshi Yasumura is currently associated with Kyowa Hakko Kogyo Co., Ltd., a leading biopharmaceutical company renowned for its innovative research and development in the healthcare sector. Throughout his career, Yasumura has been dedicated to pushing the boundaries of science and technology to improve treatment methods in medicine.
Collaborations
Yasumura has collaborated with talented colleagues such as Tatsunari Nishi and Seiga Ito. These partnerships have played a crucial role in the progression of his inventions, allowing for an exchange of ideas and expertise that fosters innovation in the biopharmaceutical realm.
Conclusion
Shigeyoshi Yasumura stands out as a distinguished inventor whose work offers promising advancements in biopharmaceuticals. His expertise and commitment to innovation continue to contribute valuable discoveries that hold the potential to positively impact patient care and treatment outcomes worldwide.